Programm                 "Degeneration und Regeneration– Grundlagen, Diagnostik und Therapie"


Hotelbuchung
   Hotel Registration
Grußwort
   Welcome address
Beteiligte Gesellschaften
   Societies involved
DOG Information
   DOG Information
Eröffnung des Kongresses
   Opening Ceremony
Preise
   Awards
Ablauf der Tagung 2003
   General overview of congress
Lageplan der Räumlichkeiten
   Map of Congress Center
Wissenschaftliche Themen
   Scientific topics
Symposien
   Symposia
Wissenschaftliches Programm
   Scientific program
Posterpräsentationen
   Poster Presentation
Kurse
   Courses
Begleitende Veranstaltungen
   Accompanying program
Arbeitssitzungen
   Working sessions
Rahmenprogramm
   Social program
Allgemeine Informationen
   General Information
Autorenindex
   Index of Authors
Industrieaussteller
   Commercial exhibitors
Sponsoren
   Sponsors
Impressum



DOG Homepage


Abstract
Abstract

Limbal Stem Cell Transplantation

Gueterich M.
University Eye Hospital, Munich, Germany

Stem cells are the ultimate source of the rapidly self-renewing corneal epithelium and are located in the basal layer of the limbal epithelium. Damage to the stem cell population causes an entity called limbal stem cell deficiency (LSCD) which is characterized by conjunctivalisation of the corneal surface. Several therapeutic strategies should be taken into account. Ocular surface defense should be restored prior to any kind of stem cell transplantation to assure a sufficient and stable tearfilm. Surgical strategies comprise superficial keratectomy with or without amniotic membrane transplantation for mild cases of LSCD. Conjunctival-limbal autograft and keratolimbal allograft transplantation are indicated in more severe cases of LSCD. A damaged limbal and corneal stroma can be restored by amniotic membrane transplantation as a biological substrate. Encouraging results have been reported using bio-engineered limbal epithelium on amniotic membrane for corneal surface reconstruction. Optimal patient selection for the respective surgical approach as well as systemic immunosuppression protocols to improve allograft survival need to be further investigated.


Zurück | Back